nicolas willand

professeur des universités
    0320964991
3ème étage, aile ouest, Faculté de Pharmacie de Lille

Parcours

Pr. Nicolas WILLAND

Date of birth: 27 February 1976

Address: Inserm U1177, “Drugs and Molecules for Living Systems”, School of Pharmacy, 3 rue du Pr. Laguesse, 59000 Lille

Phone number: (+33) 320 96 49 91

Email: nicolas.willand@univ-lille.fr

Curriculum vitae

Nicolas W. is leading a group of medicinal chemists in Benoit Deprez laboratory U1177, Drugs and Molecules for Living Systems and his research focuses on three main topics: (a) the development of new scaffolds and new synthetic pathways for the design of chemical libraries, (b) the development of new strategies to fight infectious diseases (especially tuberculosis) and (c) the design of new tools for target deconvolution based on chemical biology strategies.

 

Sept 2013 –present,

Full Professor of Organic Chemistry

University of Lille, School of Pharmacy, UMR1177, Drugs and Molecules for living systems

Heading group on « New Drugs for Infectious Diseases »

Leading medicinal chemistry projects

 

2004-2013:

Assistant Professor of Organic Chemistry

University of Lille, School of Pharmacy, UMR1177, Drugs and Molecules for living systems

2009: University of Lille, Habilitation à Diriger les Recherches

2003 - 2004: Postdoctoral researcher – School of Pharmacy Lille in collaboration with Fournier Pharma

2000 - 2003: Ph.D. in Medicinal Chemistry, University of Lille in collaboration with Ferring

Advisor: Prof. André Tartar

 

Awards

2009 : prize for the creation of innovative technologies from Oseo and the french ministry of research

2011 : Medicinal Chemistry Award from the French Society of Medicinal Chemistry (SCT) and Servier Laboratories

2016 : Innovation Prize won with Bioversys AG

 

Grants:

Coordinator of two regional-CPER grants: Tb-ET-Boost 2010, NewBio4Tb 2013

Collaborator in four ANR grants: Thioamides-Boost 2006-36 months, 2FightTB 2014-42 months, Tea-4-Two 2014-54 months, ANTI-TB-NANO 2014-60 months

Collaborator in one FRM grant: Awakening Novel Antibiotic Classes (ANAC) Programme, (2017-36 months)

Coordinator of an ANR grant : Smart-TB (2018-42 months).